Assenagon Asset Management S.A. Sells 29,557 Shares of Waters Co. (NYSE:WAT)

Assenagon Asset Management S.A. reduced its holdings in shares of Waters Co. (NYSE:WATFree Report) by 68.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,922 shares of the medical instruments supplier’s stock after selling 29,557 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Waters were worth $3,818,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in WAT. Wellington Management Group LLP boosted its stake in shares of Waters by 79.6% during the 1st quarter. Wellington Management Group LLP now owns 1,504,592 shares of the medical instruments supplier’s stock worth $467,011,000 after acquiring an additional 666,851 shares during the period. Norges Bank bought a new position in shares of Waters during the 4th quarter worth approximately $215,981,000. Alliancebernstein L.P. lifted its holdings in Waters by 37.2% during the 2nd quarter. Alliancebernstein L.P. now owns 2,018,487 shares of the medical instruments supplier’s stock worth $538,008,000 after purchasing an additional 547,777 shares during the last quarter. Van ECK Associates Corp lifted its holdings in Waters by 9,685.7% during the 2nd quarter. Van ECK Associates Corp now owns 482,339 shares of the medical instruments supplier’s stock worth $128,562,000 after purchasing an additional 477,410 shares during the last quarter. Finally, Morgan Stanley lifted its holdings in Waters by 106.7% during the 4th quarter. Morgan Stanley now owns 802,584 shares of the medical instruments supplier’s stock worth $274,950,000 after purchasing an additional 414,334 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. TheStreet raised Waters from a “c+” rating to a “b-” rating in a report on Wednesday, December 13th. Stifel Nicolaus dropped their price target on Waters from $305.00 to $290.00 and set a “hold” rating for the company in a report on Wednesday, November 8th. Wells Fargo & Company dropped their price target on Waters from $305.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, November 8th. Wolfe Research assumed coverage on Waters in a report on Wednesday, December 13th. They set a “peer perform” rating for the company. Finally, Citigroup lifted their price target on Waters from $265.00 to $300.00 and gave the stock a “neutral” rating in a report on Monday, December 11th. One equities research analyst has rated the stock with a sell rating and eight have issued a hold rating to the company’s stock. According to MarketBeat, Waters has an average rating of “Hold” and a consensus price target of $285.38.

Check Out Our Latest Stock Report on WAT

Waters Price Performance

Waters stock opened at $317.71 on Thursday. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.46 and a current ratio of 2.19. Waters Co. has a 52 week low of $231.90 and a 52 week high of $346.98. The stock has a market capitalization of $18.79 billion, a P/E ratio of 28.86, a price-to-earnings-growth ratio of 6.94 and a beta of 0.99. The stock has a fifty day moving average of $308.83 and a 200-day moving average of $283.19.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings results on Tuesday, November 7th. The medical instruments supplier reported $2.84 EPS for the quarter, topping analysts’ consensus estimates of $2.56 by $0.28. The company had revenue of $711.69 million during the quarter, compared to analysts’ expectations of $722.27 million. Waters had a return on equity of 102.22% and a net margin of 21.80%. Waters’s revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.64 EPS. On average, sell-side analysts expect that Waters Co. will post 11.69 earnings per share for the current fiscal year.

Waters Profile

(Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.